BR0112839A - Composição de eletriptano em partìculas - Google Patents
Composição de eletriptano em partìculasInfo
- Publication number
- BR0112839A BR0112839A BR0112839-6A BR0112839A BR0112839A BR 0112839 A BR0112839 A BR 0112839A BR 0112839 A BR0112839 A BR 0112839A BR 0112839 A BR0112839 A BR 0112839A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- particulate
- electriptan
- pharmaceutical composition
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electroluminescent Light Sources (AREA)
- Luminescent Compositions (AREA)
Abstract
"COMPOSIçãO DE ELETRIPTANO EM PARTìCULAS". A composição proporcina uma composição farmacêutica na forma de partículas, adequada para administração oral, incluindo um núcleo contendo eletriptano ou um seu sal fermaceuticamente aceitável, um núcleo revestido com um revestimento permeável, insolúvel em água, incluindo um ou mais copolímero(s) acrílico(s) contendo grupos metilmetacrilato de trimetilamónio, sendo esta composição capaz de atingir um padrão sigmoidal de liberação controlada de droga. Esta composição farmacêutica é particularmente adequada na prevenção da enxaqueca recorrente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0018968.8A GB0018968D0 (en) | 2000-08-02 | 2000-08-02 | Particulate composition |
PCT/IB2001/001279 WO2002009675A1 (en) | 2000-08-02 | 2001-07-18 | Particulate composition of eletriptan showing a sigmoidal pattern of controlled release |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0112839A true BR0112839A (pt) | 2003-06-24 |
Family
ID=9896843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0112839-6A BR0112839A (pt) | 2000-08-02 | 2001-07-18 | Composição de eletriptano em partìculas |
Country Status (38)
Country | Link |
---|---|
US (1) | US20020034545A1 (pt) |
EP (1) | EP1365748B1 (pt) |
JP (1) | JP2004505034A (pt) |
KR (1) | KR20030024820A (pt) |
CN (1) | CN1630511A (pt) |
AP (1) | AP2001002233A0 (pt) |
AR (1) | AR030099A1 (pt) |
AT (1) | ATE308978T1 (pt) |
AU (1) | AU2001270932A1 (pt) |
BG (1) | BG107361A (pt) |
BR (1) | BR0112839A (pt) |
CA (1) | CA2417887C (pt) |
CZ (1) | CZ2003241A3 (pt) |
DE (1) | DE60114887T2 (pt) |
EA (1) | EA200300110A1 (pt) |
EC (1) | ECSP034451A (pt) |
EE (1) | EE200300051A (pt) |
ES (1) | ES2250429T3 (pt) |
GB (1) | GB0018968D0 (pt) |
GT (1) | GT200100149A (pt) |
HR (1) | HRP20030036A2 (pt) |
HU (1) | HUP0301453A2 (pt) |
IL (1) | IL153494A0 (pt) |
IS (1) | IS6649A (pt) |
MA (1) | MA26934A1 (pt) |
MX (1) | MXPA03000999A (pt) |
NO (1) | NO20030498D0 (pt) |
NZ (1) | NZ522976A (pt) |
OA (1) | OA12348A (pt) |
PA (1) | PA8523101A1 (pt) |
PE (1) | PE20020385A1 (pt) |
PL (1) | PL359847A1 (pt) |
SK (1) | SK1082003A3 (pt) |
SV (1) | SV2002000574A (pt) |
TN (1) | TNSN01115A1 (pt) |
UY (1) | UY26861A1 (pt) |
WO (1) | WO2002009675A1 (pt) |
ZA (1) | ZA200300868B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040022853A1 (en) * | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
AU2003294520A1 (en) * | 2002-12-16 | 2004-07-09 | Chx Technologies, Inc. | Temporary, pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing |
BRPI0409127A (pt) * | 2003-04-11 | 2006-03-28 | Pfizer | combinação farmacêutica compreendendo eletriptano e bicarbonato de sódio |
GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
WO2005120456A2 (en) * | 2004-06-09 | 2005-12-22 | Pfizer Limited | Formulation of eletriptan |
WO2006013431A1 (en) * | 2004-07-29 | 2006-02-09 | Pfizer Limited | Stable controlled-release pharmaceutical formulation of eletriptan |
CA2596548A1 (en) * | 2005-01-31 | 2006-08-03 | Kyorin Pharmaceutical Co., Ltd. | Multiple unit oral sustained release preparation and process for production of the same |
DK1915137T3 (da) | 2005-08-10 | 2013-11-04 | Add Advanced Drug Delivery Technologies Ltd | Oralt præparat med kontrolleret frisætning |
US20070134322A1 (en) * | 2005-12-14 | 2007-06-14 | Forest Laboratories, Inc. | Modified and pulsatile release pharmaceutical formulations of escitalopram |
EP2359830B1 (en) * | 2006-04-26 | 2012-09-19 | Supernus Pharmaceuticals, Inc. | Controlled released preparations of oxcarbazepine having sigmoidal release profile |
WO2008115797A1 (en) * | 2007-03-16 | 2008-09-25 | Pavo, Inc. | Therapeutic compositions and methods |
EP2175865A4 (en) | 2007-07-25 | 2012-01-11 | Biolex Therapeutics Inc | INTERFERON DRUG PRODUCTS WITH CONTROLLED RELEASE AND TREATMENT OF HCV INFECTIONS THEREWITH |
CN102665695A (zh) | 2009-11-16 | 2012-09-12 | 赢创罗姆有限公司 | 借助分散剂将固体(甲基)丙烯酸酯共聚物转化成分散形式的方法 |
EP3191093A4 (en) * | 2014-09-09 | 2018-04-25 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
GB201716716D0 (en) * | 2017-10-12 | 2017-11-29 | Univ Of Hertfordshire Higher Education Corporation | Method for coating particles |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2624732B1 (fr) * | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
US5411745A (en) * | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
GB9922963D0 (en) * | 1999-09-28 | 1999-12-01 | Pfizer Ltd | Polymorphic salt |
FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
-
2000
- 2000-08-02 GB GBGB0018968.8A patent/GB0018968D0/en not_active Ceased
-
2001
- 2001-07-18 AT AT01949819T patent/ATE308978T1/de not_active IP Right Cessation
- 2001-07-18 NZ NZ522976A patent/NZ522976A/en unknown
- 2001-07-18 WO PCT/IB2001/001279 patent/WO2002009675A1/en active IP Right Grant
- 2001-07-18 DE DE60114887T patent/DE60114887T2/de not_active Expired - Lifetime
- 2001-07-18 KR KR10-2003-7001402A patent/KR20030024820A/ko not_active Application Discontinuation
- 2001-07-18 CA CA002417887A patent/CA2417887C/en not_active Expired - Fee Related
- 2001-07-18 AP APAP/P/2001/002233A patent/AP2001002233A0/en unknown
- 2001-07-18 PL PL35984701A patent/PL359847A1/xx not_active Application Discontinuation
- 2001-07-18 EE EEP200300051A patent/EE200300051A/xx unknown
- 2001-07-18 CN CNA018134041A patent/CN1630511A/zh active Pending
- 2001-07-18 ES ES01949819T patent/ES2250429T3/es not_active Expired - Lifetime
- 2001-07-18 EA EA200300110A patent/EA200300110A1/ru unknown
- 2001-07-18 CZ CZ2003241A patent/CZ2003241A3/cs unknown
- 2001-07-18 IL IL15349401A patent/IL153494A0/xx unknown
- 2001-07-18 BR BR0112839-6A patent/BR0112839A/pt not_active Application Discontinuation
- 2001-07-18 HU HU0301453A patent/HUP0301453A2/hu unknown
- 2001-07-18 MX MXPA03000999A patent/MXPA03000999A/es active IP Right Grant
- 2001-07-18 OA OA1200300020A patent/OA12348A/en unknown
- 2001-07-18 EP EP01949819A patent/EP1365748B1/en not_active Expired - Lifetime
- 2001-07-18 SK SK108-2003A patent/SK1082003A3/sk not_active Application Discontinuation
- 2001-07-18 JP JP2002515228A patent/JP2004505034A/ja active Pending
- 2001-07-18 AU AU2001270932A patent/AU2001270932A1/en not_active Abandoned
- 2001-07-25 GT GT200100149A patent/GT200100149A/es unknown
- 2001-07-25 US US09/912,774 patent/US20020034545A1/en not_active Abandoned
- 2001-07-25 PA PA20018523101A patent/PA8523101A1/es unknown
- 2001-07-30 UY UY26861A patent/UY26861A1/es not_active Application Discontinuation
- 2001-07-30 SV SV2001000574A patent/SV2002000574A/es not_active Application Discontinuation
- 2001-08-01 AR ARP010103668A patent/AR030099A1/es unknown
- 2001-08-01 PE PE2001000770A patent/PE20020385A1/es not_active Application Discontinuation
- 2001-08-01 TN TNTNSN01115A patent/TNSN01115A1/fr unknown
-
2002
- 2002-12-05 IS IS6649A patent/IS6649A/is unknown
- 2002-12-06 BG BG107361A patent/BG107361A/bg unknown
-
2003
- 2003-01-21 HR HR20030036A patent/HRP20030036A2/hr not_active Application Discontinuation
- 2003-01-23 MA MA27009A patent/MA26934A1/fr unknown
- 2003-01-24 EC EC2003004451A patent/ECSP034451A/es unknown
- 2003-01-31 ZA ZA200300868A patent/ZA200300868B/en unknown
- 2003-01-31 NO NO20030498A patent/NO20030498D0/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0112839A (pt) | Composição de eletriptano em partìculas | |
BRPI0309142C1 (pt) | suspensão de microcápsulas em uma fase líquida aquosa, que permite a liberação modificada de pelo menos um princípio ativo com exclusão da amoxicilina e que é destinada a ser administrada por via oral | |
ATE213629T1 (de) | Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe | |
DE69427568T2 (de) | Rasch freisetzende Tablettenkerne mit unlöslichen Arzneistoffen und mit einem Retardüberzug | |
BRPI0518266B8 (pt) | medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular | |
EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
BR0114633A (pt) | Formulações farmacêuticas com liberação retardada | |
CA2065809A1 (en) | Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids | |
BR0202375A (pt) | Composições farmacêutica compreendendo drogas e polìmeros de aumento da concentração | |
BR9904039A (pt) | Preparação de partìculas farmaceuticamente ativas | |
BRPI0408999A (pt) | comprimidos prensados de multiparticulados de liberação oral prolongada | |
ATE266390T1 (de) | Stossweise freisetzende arzneiabgabesysteme | |
CA2065652A1 (en) | Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts | |
ATE246505T1 (de) | Zubereitung enthaltend cefaclor oder cephalexin mit modifizierter freisetzungsmatrix | |
RS54050B1 (en) | FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS | |
BR9917012A (pt) | Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral | |
BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
EA200001201A2 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
KR950031052A (ko) | 알푸조신 히드로클로라이드의 서방성 투약형태 | |
DE60042168D1 (de) | Chronotherapeutische diltiazem formulierungen und deren verabreichung | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
ATE367153T1 (de) | Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme | |
UA74335C2 (uk) | Мультичастинкова композиція контрольованого вивільнення флувоксаміну та спосіб лікування станів, які лікуються за допомогою селективних інгібіторів зворотного захоплення серотоніну | |
RS20060413A (en) | Non-disintegrating oral solid composition of high dose of water soluble drugs | |
CR6858A (es) | Composiciones de eletriptan en forma de particulas que muestra el curso sigmoideo de liberacion controlada |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |